Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study

被引:29
作者
von Hoff, Katja [1 ,2 ,3 ]
Haberler, Christine [4 ]
Schmitt-Hoffner, Felix [5 ,6 ,7 ,8 ]
Schepke, Elizabeth [9 ]
de Rojas, Teresa [10 ]
Jacobs, Sandra [11 ,12 ]
Zapotocky, Michal [13 ,14 ]
Sumerauer, David [13 ,14 ]
Perek-Polnik, Marta [15 ]
Dufour, Christelle [16 ,17 ]
van Vuurden, Dannis [18 ]
Slavc, Irene [19 ]
Gojo, Johannes [19 ]
Pickles, Jessica C. [20 ,21 ]
Gerber, Nicolas U. [22 ]
Massimino, Maura [23 ]
Gil-da-Costa, Maria Joao [24 ]
Garami, Miklos [25 ]
Kumirova, Ella [26 ]
Sehested, Astrid [27 ]
Scheie, David [28 ]
Cruz, Ofelia [29 ]
Moreno, Lucas [30 ]
Cho, Jaeho [31 ]
Zeller, Bernward [32 ]
Bovenschen, Niels [33 ]
Grotzer, Michael [22 ]
Alderete, Daniel [34 ]
Snuderl, Matija [35 ,36 ]
Zheludkova, Olga [37 ]
Golanov, Andrey [38 ]
Okonechnikov, Konstantin [5 ,6 ,7 ]
Mynarek, Martin [39 ]
Juhnke, Bjoern Ole [39 ]
Rutkowski, Stefan [39 ]
Schuller, Ulrich [39 ,40 ,41 ]
Pizer, Barry [42 ]
von Zezschwitz, Barbara [1 ,2 ,3 ]
Kwiecien, Robert [43 ]
Wechsung, Maximilian [44 ]
Konietschke, Frank [44 ]
Hwang, Eugene, I [45 ]
Sturm, Dominik [5 ,7 ,46 ,47 ]
Pfister, Stefan M. [5 ,6 ,7 ,47 ]
von Deimling, Andreas [48 ,49 ]
Rushing, Elisabeth J. [50 ]
Ryzhova, Marina [51 ]
Hauser, Peter [25 ]
Lastowska, Maria [52 ]
Wesseling, Pieter [18 ,53 ]
机构
[1] Charite Univ Med Berlin, Dept Pediat Oncol & Hematol, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria
[5] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany
[6] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany
[7] German Canc Consortium DKTK, Heidelberg, Germany
[8] Heidelberg Univ, Fac Biosci, Heidelberg, Germany
[9] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden
[10] Childrens Univ Hosp Nino Jesus, Pediat OncoGen Unit, Madrid, Spain
[11] Katholieke Univ Leuven, Dept Pediat, Leuven, Belgium
[12] Univ Hosp Leuven, Leuven, Belgium
[13] Charles Univ Prague, Fac Med 2, Prague, Czech Republic
[14] Univ Hosp Motol, Prague, Czech Republic
[15] Univ Warsaw, Childrens Mem Hlth Inst, Dept Oncol, Warsaw, Poland
[16] Gustave Roussy Canc Ctr, Dept Pediat & Adolescent Oncol, Villejuif, France
[17] Paris Saclay Univ, Mol Predictors & New Targets Oncol, INSERM, Villejuif, France
[18] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[19] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria
[20] UCL Great Ormond St Inst Child Hlth, Dev Biol & Canc Res & Teaching Dept, London, England
[21] Great Ormond St Hosp Children NHS Fdn Trust, Dept Histopathol, London, England
[22] Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland
[23] Fdn IRCCS Ist Nazl Tumori, Pediat Unit, Milan, Italy
[24] Univ Hosp Sao Joao, Pediat Oncol Dept, Porto, Portugal
[25] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary
[26] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol, Dept Neurooncol, Moscow, Russia
[27] Rigshosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark
[28] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark
[29] Hosp St Joan de Deu, Pediat Oncol Dept, Barcelona, Spain
[30] Hosp Univ Vall dHebron, Paediat Haematol & Oncol Div, Barcelona, Spain
[31] Yonsei Univ, Yonsei Canc Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea
[32] Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway
[33] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[34] Hosp JP Garrahan, Serv Hematol Oncol, Buenos Aires, DF, Argentina
[35] NYU Langone Hlth, Dept Pathol, New York, NY USA
[36] Sch Med, New York, NY USA
[37] Russian Sci Ctr Radiol, Dept Neurooncol, Moscow, Russia
[38] Burdenko Neurosurg Inst, Dept Neuroradiol, Moscow, Russia
[39] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany
[40] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany
[41] Childrens Canc Ctr Hamburg, Res Inst, Hamburg, Germany
[42] Univ Liverpool, Inst Translat Res, Liverpool, Merseyside, England
[43] Univ Munster, Inst Biostat & Clin Res, Munster, Germany
[44] Charite, Inst Biometry & Clin Epidemiol, Berlin, Germany
[45] Childrens Natl Med Ctr, Ctr Canc & Immunol Res & Neurosci Res, Dept Pediat Hematol Oncol, Washington, DC 20010 USA
[46] German Canc Res Ctr, Pediat Glioma Res, Heidelberg, Germany
[47] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[48] Heidelberg Univ Hosp, Dept Neuropathol, Heidelberg, Germany
[49] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany
[50] Univ Med Ctr Zurich, Inst Neuropathol, Zurich, Switzerland
基金
英国医学研究理事会;
关键词
CNS embryonal tumor; CNS NB-FOXR2; CNS-PNET; DNA methylation profiling; ETMR; PRIMITIVE NEUROECTODERMAL TUMOR; PRIMARY CEREBRAL NEUROBLASTOMA; HIGH-RISK MEDULLOBLASTOMA; HIGH-DOSE CHEMOTHERAPY; STEM-CELL RESCUE; YOUNG-CHILDREN; RADIATION-THERAPY; INTENSIVE CHEMOTHERAPY; MULTILAYERED ROSETTES; PROGNOSTIC-FACTORS;
D O I
10.1093/neuonc/noab136
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Only few data are available on treatment-associated behavior of distinct rare CNS embryonal tumor entities previously treated as "CNS-primitive neuroectodermal tumors" (CNS-PNET). Respective data on specific entities, including CNS neuroblastoma, FOXR2 activated (CNS NB-FOXR2), and embryonal tumors with multilayered rosettes (ETMR) are needed for development of differentiated treatment strategies. Methods. Within this retrospective, international study, tumor samples of clinically well-annotated patients with the original diagnosis of CNS-PNET were analyzed using DNA methylation arrays (n = 307). Additional cases (n = 66) with DNA methylation pattern of CNS NB-FOXR2 were included irrespective of initial histological diagnosis. Pooled clinical data (n = 292) were descriptively analyzed. Results. DNA methylation profiling of "CNS-PNET" classified 58 (19%) cases as ETMR, 57 (19%) as high-grade glioma (HGG), 36 (12%) as CNS NB-FOXR2, and 89(29%) cases were classified into 18 other entities. Sixty-seven (22%) cases did not show DNA methylation patterns similar to established CNS tumor reference classes. Best treatment results were achieved for CNS NB-FOXR2 patients (5-year PFS: 63% 7%, OS: 85% +/- 5%, n = 63), with 35/42 progression-free survivors after upfront craniospinal irradiation (CSI) and chemotherapy. The worst outcome was seen for ETMR and HGG patients with 5-year PFS of 18% +/- 6% and 22% +/- 7%, and 5-year OS of 24% +/- 6% and 25% +/- 7%, respectively. Conclusion. The historically reported poor outcome of CNS-PNET patients becomes highly variable when tumors are molecularly classified based on DNA methylation profiling. Patients with CNS NB-FOXR2 responded well to current treatments and a standard-risk CSI-based regimen may be prospectively evaluated. The poor outcome of ETMR across applied treatment strategies substantiates the necessity for evaluation of novel treatments.
引用
收藏
页码:1597 / 1611
页数:15
相关论文
共 61 条
[41]   Supratentorial primitive neuroectodermal tumors (S-PNET) in in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy [J].
Massimino, M ;
Gandola, L ;
Spreafico, F ;
Luksch, R ;
Collini, P ;
Giangaspero, F ;
Simonetti, F ;
Casanova, M ;
Cefalo, G ;
Pignoli, E ;
Ferrari, A ;
Terenziani, M ;
Podda, M ;
Meazza, C ;
Polastri, D ;
Poggi, G ;
Ravagnani, F ;
Fossati-Bellani, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04) :1031-1037
[42]   Evolving of Therapeutic Strategies for CNS-PNET [J].
Massimino, Maura ;
Gandola, Lorenza ;
Biassoni, Veronica ;
Spreafico, Filippo ;
Schiavello, Elisabetta ;
Poggi, Geraldina ;
Pecori, Emilia ;
De Pava, Marco Vajna ;
Modena, Piergiorgio ;
Antonelli, Manila ;
Giangaspero, Felice .
PEDIATRIC BLOOD & CANCER, 2013, 60 (12) :2031-2035
[43]   Evaluation of the good tumor response of embryonal tumor with abundant neuropil and true rosettes (ETANTR) [J].
Mozes, Petra ;
Hauser, Peter ;
Hortobagyi, Tibor ;
Benyo, Gabor ;
Petak, Istvan ;
Garami, Miklos ;
Cserhati, Adrienne ;
Bartyik, Katalin ;
Bognar, Laszlo ;
Nagy, Zoltan ;
Turanyi, Eszter ;
Hideghety, Katalin .
JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (01) :99-105
[44]   Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort [J].
Mynarek, Martin ;
von Hoff, Katja ;
Pietsch, Torsten ;
Ottensmeier, Holger ;
Warmuth-Metz, Monika ;
Bison, Brigitte ;
Pfister, Stefan ;
Korshunov, Andrey ;
Sharma, Tanvi ;
Jaeger, Natalie ;
Ryzhova, Marina ;
Zheludkova, Olga ;
Golanov, Andrey ;
Rushing, Elisabeth Jane ;
Hasselblatt, Martin ;
Koch, Arend ;
Schueller, Ulrich ;
von Deimling, Andreas ;
Sahm, Felix ;
Sill, Martin ;
Riemenschneider, Markus J. ;
Dohmen, Hildegard ;
Monoranu, Camelia Maria ;
Sommer, Clemens ;
Staszewski, Ori ;
Mawrin, Christian ;
Schittenhelm, Jens ;
Brueck, Wolfgang ;
Filipski, Katharina ;
Hartmann, Christian ;
Meinhardt, Matthias ;
Pietschmann, Klaus ;
Haberler, Christine ;
Slavc, Irene ;
Gerber, Nicolas U. ;
Grotzer, Michael ;
Benesch, Martin ;
Schlegel, Paul Gerhardt ;
Deinlein, Frank ;
von Bueren, Andre O. ;
Friedrich, Carsten ;
Juhnke, Bjoern-Ole ;
Obrecht, Denise ;
Fleischhack, Gudrun ;
Kwiecien, Robert ;
Faldum, Andreas ;
Kortmann, Rolf Dieter ;
Kool, Marcel ;
Rutkowski, Stefan .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (18) :2028-+
[45]   A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors [J].
Neumann, Julia E. ;
Wefers, Annika K. ;
Lambo, Sander ;
Bianchi, Edoardo ;
Bockstaller, Marie ;
Dorostkar, Mario M. ;
Meister, Valerie ;
Schindler, Pia ;
Korshunov, Andrey ;
von Hoff, Katja ;
Nowak, Johannes ;
Warmuth-Metz, Monika ;
Schneider, Marlon R. ;
Renner-Mueller, Ingrid ;
Merk, Daniel J. ;
Shakarami, Mehdi ;
Sharma, Tanvi ;
Chavez, Lukas ;
Glass, Rainer ;
Chan, Jennifer A. ;
Taketo, M. Mark ;
Neumann, Philipp ;
Kool, Marcel ;
Schueller, Ulrich .
NATURE MEDICINE, 2017, 23 (10) :1191-+
[46]   Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A children's cancer group study [J].
Packer, RJ ;
Goldwein, J ;
Nicholson, HS ;
Vezina, LG ;
Allen, JC ;
Ris, MD ;
Muraszko, K ;
Rorke, LB ;
Wara, WM ;
Cohen, BH ;
Boyett, JM .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2127-2136
[47]  
Perek Danuta, 2003, Med Wieku Rozwoj, V7, P201
[48]   Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes [J].
Pfister, Stefan ;
Remke, Marc ;
Castoldi, Mirco ;
Bai, Alfa H. C. ;
Muckenthaler, Martina U. ;
Kulozik, Andreas ;
von Deimling, Andreas ;
Pscherer, Armin ;
Lichter, Peter ;
Korshunov, Andrey .
ACTA NEUROPATHOLOGICA, 2009, 117 (04) :457-464
[49]   Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study [J].
Pizer, BL ;
Weston, CL ;
Robinson, KJ ;
Ellison, DW ;
Ironside, J ;
Saran, F ;
Lashford, LS ;
Tait, D ;
Lucraft, H ;
Walker, DA ;
Bailey, CC ;
Taylor, RE .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1120-1128
[50]   Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities [J].
Reuss, David E. ;
Kratz, Annekathrin ;
Sahm, Felix ;
Capper, David ;
Schrimpf, Daniel ;
Koelsche, Christian ;
Hovestadt, Volker ;
Bewerunge-Hudler, Melanie ;
Jones, David T. W. ;
Schittenhelm, Jens ;
Mittelbronn, Michel ;
Rushing, Elisabeth ;
Simon, Matthias ;
Westphal, Manfred ;
Unterberg, Andreas ;
Platten, Michael ;
Paulus, Werner ;
Reifenberger, Guido ;
Tonn, Joerg-Christian ;
Aldape, Kenneth ;
Pfister, Stefan M. ;
Korshunov, Andrey ;
Weller, Michael ;
Herold-Mende, Christel ;
Wick, Wolfgang ;
Brandner, Sebastian ;
von Deimling, Andreas .
ACTA NEUROPATHOLOGICA, 2015, 130 (03) :407-417